Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Wolfe, C. D.  [Clear All Filters]
Journal Article
A. M. Toschke, Gulliford, M. C., Wolfe, C. D., Rudd, A. G., and Heuschmann, P. U., Antihypertensive treatment after first stroke in primary care: results from the General Practitioner Research Database, J Hypertens, vol. 29, pp. 154-60, 2011.
A. M. Toschke, Wolfe, C. D., Heuschmann, P. U., Rudd, A. G., and Gulliford, M., Antihypertensive treatment after stroke and all-cause mortality–an analysis of the General Practitioner Research Database (GPRD), Cerebrovasc Dis, vol. 28, pp. 105-11, 2009.
M. C. Gulliford, Charlton, J., Rudd, A., Wolfe, C. D., and Toschke, A. M., Declining 1-year case-fatality of stroke and increasing coverage of vascular risk management: population-based cohort study, J Neurol Neurosurg Psychiatry, vol. 81, pp. 416-22, 2010.
A. Dregan, van Staa, T. P., McDermott, L., McCann, G., Ashworth, M., Charlton, J., Wolfe, C. D., Rudd, A., Yardley, L., Gulliford, M. C., and Steering, C. Trial, Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records, Stroke, vol. 45, pp. 2066-71, 2014.
A. Dregan, Charlton, J., Wolfe, C. D., Gulliford, M. C., and Markus, H. S., Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study, Pharmacoepidemiol Drug Saf, vol. 23, pp. 759-67, 2014.
A. Dregan, Toschke, M. A., Wolfe, C. D., Rudd, A., Ashworth, M., and Gulliford, M. C., Utility of electronic patient records in primary care for stroke secondary prevention trials, BMC Public Health, vol. 11, p. 86, 2011.
[Page last reviewed 4 March 2021]